ArticlePhysiological reports2025
Effects of an astaxanthin-containing supplement on oxidative status in skeletal muscle and circulation during deconditioning and reconditioning periods in polo ponies.
Article in Physiological reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Mitochondrial Adaptations to Exercise Training in Equine Skeletal Muscle: A Narrative Review.Life (Basel, Switzerland) · 2026Review
- Nutraceutical Potential of Astaxanthin in Muscle Metabolism, Exercise Adaptation, and Obesity.Nutrients · 2025Review
- Effects of an astaxanthin-containing supplement on oxidative status in skeletal muscle and circulation during deconditioning and reconditioning periods in polo ponies.Physiological reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
This study investigated the effects of astaxanthin (ASTX) supplementation on oxidative status during a deconditioning-reconditioning cycle. Twelve polo ponies were assigned to no supplementation (CON) or an ASTX supplemented group, which received oral administration of a supplement containing 75 mg ASTX daily for 32 weeks. Polo ponies underwent a 16-week deconditioning period (DECON) followed by a 16-week reconditioning program (RECON). Submaximal exercise tests (SETs) were performed at the beginning of the study (Baseline), after DECON, and after RECON. Blood samples were collected at -30, 0, 15, 30, and 60 min relative to each SET for oxidative status analysis. Muscle samples were collected 2 weeks before (Pre-Ex) and 2 h after (Post-Ex) each SET for muscle oxidative status and gene expression analyses. Pre-Ex muscles were analyzed for high-resolution respirometry. Circulating glutathione peroxidase (GPX) activity was increased (p ≤ 0.02) and protein carbonylation was decreased in ASTX (p ≤ 0.05). Muscle oxidative status was affected by DECON and reconditioning (p ≤ 0.05). ASTX increased gene expression of PPARGC1A after reconditioning (p ≤ 0.05). Deconditioning reduced oxidative phosphorylation at complex I and II (p = 0.01). Thus, a deconditioning-reconditioning cycle had greater impacts on muscle oxidative capacity than ASTX supplementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.